No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people with HIV with profound immunosuppression
HIV Medicine · 2024
DOI: 10.1111/hiv.13695 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2024. Verfasst von Chi Kuen Chan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health, Tuberculosis and Chest Service, Public Health Services Branch, Centre for Health Protection, Hong Kong, China. Hauptthemen laut MEDLINE: Immune Reconstitution Inflammatory Syndrome, HIV Infections, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Introduction
The issue of whether integrase inhibitors (INSTIs) may confer a higher risk of paradoxical tuberculosis‐related immune reconstitution inflammatory syndrome (TB‐IRIS) compared with other classes of antiretroviral in people with HIV with a profound level of immunosuppression remains insufficiently explored. We aimed to assess whether such a higher risk exists by examining a cohort of patients with TB‐HIV initiating antiretroviral therapy (ART) in Hong Kong.
Methods
This was a retrospective review of 133 patients registered in the TB‐HIV Registry of the Department of Health during the period 2014–2021.
Results
Sixteen of 70 patients (22.9%; 95% confidence interval [CI] 13.0–32.7) and 14 of 63 patients (22.2%; 95% CI 12.0–32.5) from the INSTI and non‐INSTI groups experienced TB‐IRIS ( p = 0.920). The median intervals between ART initiation and IRIS among patients from the two groups were similar (3 weeks [interquartile range IQR 2.0–7.8] vs. 4 weeks [IQR 2.0–5.1], p = 0.620). The proportion of patients requiring steroid therapy were similar, as were the hospitalization rates. There was no IRIS‐related death in either group. The risk of TB‐IRIS with INSTI versus non‐INSTI was also similar in a stratified analysis in a subgroup of patients with a baseline CD4 count of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health, Tuberculosis and Chest Service, Public Health Services Branch, Centre for Health Protection, Hong Kong, China.
- Department of Health, Special Preventive Programme, Public Health Services Branch, Centre for Health Protection, Hong Kong, China.
- Hong Kong Tuberculosis, Chest and Heart Diseases Association, Hong Kong, China.
- Department of Medicine, Queen Elizabeth Hospital, Hong Kong, China.
- Department of Medicine, Princess Margaret Hospital, Hong Kong, China.
ORCID-Profile: Chi Kuen Chan
Zitieren
APA
Chan, C. K., Huang, S. S., Wong, K. H., Leung, C. C., Lee, M. P., Tsang, T. Y., Wong, C. K. B., Lee, S. N., Law, W. S., & Tai, L. B. (2024). No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people with HIV with profound immunosuppression. HIV Medicine. https://doi.org/10.1111/hiv.13695
Vancouver
Chan CK, Huang SS, Wong KH, Leung CC, Lee MP, Tsang TY, et al. No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people with HIV with profound immunosuppression. HIV Medicine. 2024. doi:10.1111/hiv.13695
BibTeX
@article{Chan2024,
author = {Chan, Chi Kuen and Huang, Shan Shan and Wong, Ka Hing and Leung, Chi Chiu and Lee, Man Po and Tsang, Tak Yin and Wong, Chun Kwan Bonnie and Lee, Shuk Nor and Law, Wing Sze and Tai, Lai Bun},
title = {No increased risk of tuberculosis‐related immune reconstitution inflammatory syndrome with integrase inhibitor‐based antiretroviral therapy in people with HIV with profound immunosuppression},
journal = {HIV Medicine},
year = {2024},
doi = {10.1111/hiv.13695}
}
EUVIMED